The USPTO published Kobuk Therapeutics' Intent-to-Use trademark application for 'KOBUK THERAPEUTICS' covering pharmaceutical preparations and substances in Nice Class 5. The application was filed March 27, 2025, under registration number TM99107436. The goods description encompasses pharmaceutical preparations for treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system diseases and disorders.

Trademark applicants or competitors in the pharmaceutical space should review the goods and services description for potential conflicts. The USPTO will examine the application and, if approved, publish it for opposition. Third parties will have an opportunity to oppose registration during the opposition period. No immediate compliance action is required from pharmaceutical companies, though trademark counsel should monitor for publication and potential opposition proceedings.